A detailed history of Horizon Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Horizon Financial Services, LLC holds 35 shares of ABBV stock, worth $6,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 69 49.28%
Holding current value
$6,134
Previous $11,000 45.45%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $5,570 - $6,777
-34 Reduced 49.28%
35 $6,000
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $4,488 - $5,242
29 Added 72.5%
69 $11,000
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $6,392 - $7,284
40 New
40 $7,000
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $5,279 - $6,550
-40 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $1,074 - $1,359
10 Added 33.33%
40 $5,000
Q1 2021

Apr 21, 2021

BUY
$102.3 - $112.62 $3,069 - $3,378
30 New
30 $3,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Horizon Financial Services, LLC Portfolio

Follow Horizon Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Financial Services, LLC with notifications on news.